Valent BioSciences launches new public health website

Date:06-11-2012

Valent BioSciences Corporation (VBC) announced the launch of its dedicated Public Health website, publichealth.valentbiosciences.com. The new site serves as a fundamental resource for useful information in the ongoing battle against nuisance and disease vectoring insects. It also prescribes product solutions to challenges Public Health officials face on a daily basis.

VBC began developing the site in 2011, with guidance from key Public Health professionals from around the globe. VBC is a global leader in the development and commercialization of biorational control solutions for insects of public health concern, including advanced microbial larvicide formulations used to control mosquito populations.

"The development of this website supports VBC's commitment to working alongside its customers to bring forth innovative and custom solutions," said Ernest Dankwa, Senior Global Business Manager for VBC's Public Health and Forestry Business Unit, "We are confident that this will be an effective informational tool for our customers and public health policy makers worldwide as we join forces in protecting human potential."

The website's simple navigation provides easy access to in-depth information on key diseases of public health concern including Malaria, Dengue fever, Encephalitis, West Nile virus, Chikungunya, Yellow Fever and Filariasis. The site also provides critical information on the primary mosquito species of public health concern including Aedes, Culex, and Anopheles, and the habitats in which they are found.

A key feature for Public Health Officials is a portal containing product labels and MSDS documentation for recommended controls, as well as a searchable resource center linked to technical use bulletins and related publication search sites. Visitors will also learn about the benefits of employing an Integrated Vector Management strategy to maximize results, including VBC's latest mosquito control solutions VectoMax® and MetaLarvTM and its core products VectoBac® and VectoLex®.